COVID-19 vaccines and the role of patents
by Kelli Larson
International Journal of Intellectual Property Management (IJIPM), Vol. 11, No. 4, 2021

Abstract: In a remarkable feat of science and technology, several vaccines have been developed at a rapid pace to combat the global coronavirus (COVID-19) disease. It is a sign of what can be achieved for humankind with sufficient funding and investment in science and technology, accompanied by intellectual property laws that provide incentives to innovate. Patents help provide that incentive. Patents form part of a strong innovation ecosystem and play a significant role in ensuring that there is an incentive for entities to engage in innovation that may benefit society. Patents play a critical role in incentivising innovation, including incentivising the development of new vaccines. The valuable information disclosed in a patent specification allows for the public dissemination of knowledge to occur, allowing others to learn from current inventions and to build from them to create new and potentially life-saving innovations.

Online publication date: Wed, 03-Nov-2021

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Intellectual Property Management (IJIPM):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com